METOPROLOL SUCCINATE ER TABLETS

METOPROLOL SUCCINATE ER TABLETS was reported 63972 times

These side effects are most commonly reported by patients taking METOPROLOL SUCCINATE ER TABLETS:

# Side effect Count
0 FATIGUE 4958
1 DIARRHOEA 4072
2 DYSPNOEA 3873
3 NAUSEA 3810
4 DIZZINESS 3236
5 DRUG INEFFECTIVE 3139
6 OFF LABEL USE 3102
7 HEADACHE 2968
8 DEATH 2651
9 ASTHENIA 2453
10 PAIN 2316
11 FALL 2215
12 COUGH 2081
13 PNEUMONIA 1971
14 VOMITING 1908
15 PRODUCT DOSE OMISSION ISSUE 1843
16 PRURITUS 1797
17 WEIGHT DECREASED 1746
18 ARTHRALGIA 1726
19 RASH 1713
20 HYPOTENSION 1712
21 MALAISE 1662
22 HYPERTENSION 1573
23 ATRIAL FIBRILLATION 1545
24 DECREASED APPETITE 1503
25 PAIN IN EXTREMITY 1439
26 CONSTIPATION 1404
27 BACK PAIN 1309
28 BLOOD PRESSURE INCREASED 1299
29 CHEST PAIN 1282
30 URINARY TRACT INFECTION 1277
31 INSOMNIA 1255
32 MYOCARDIAL INFARCTION 1209
33 ANXIETY 1130
34 CONDITION AGGRAVATED 1099
35 FEELING ABNORMAL 1089
36 PRODUCT USE IN UNAPPROVED INDICATION 1076
37 PERIPHERAL SWELLING 1073
38 ACUTE KIDNEY INJURY 1067
39 DRUG INTERACTION 1042
40 ANAEMIA 1035
41 COVID-19 1028
42 PYREXIA 1010
43 GAIT DISTURBANCE 996
44 RENAL FAILURE 994
45 ABDOMINAL DISCOMFORT 961
46 DEHYDRATION 947
47 DEPRESSION 935
48 WEIGHT INCREASED 935
49 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 911
50 PALPITATIONS 896
51 ABDOMINAL PAIN UPPER 894
52 NASOPHARYNGITIS 881
53 HEART RATE INCREASED 860
54 SOMNOLENCE 855
55 OEDEMA PERIPHERAL 853
56 MUSCLE SPASMS 850
57 CEREBROVASCULAR ACCIDENT 806
58 CONFUSIONAL STATE 806
59 CHRONIC KIDNEY DISEASE 768
60 MYALGIA 768
61 ABDOMINAL PAIN 764
62 HAEMOGLOBIN DECREASED 755
63 CARDIAC FAILURE CONGESTIVE 741
64 SYNCOPE 724
65 CARDIAC DISORDER 713
66 EYE PAIN 704
67 MUSCULAR WEAKNESS 690
68 CHEST DISCOMFORT 686
69 TREMOR 682
70 CONTUSION 681
71 ALOPECIA 676
72 MEMORY IMPAIRMENT 675
73 CARDIAC FAILURE 674
74 BLOOD GLUCOSE INCREASED 666
75 VISION BLURRED 661
76 LOSS OF CONSCIOUSNESS 647
77 PLATELET COUNT DECREASED 647
78 GASTROINTESTINAL HAEMORRHAGE 632
79 PRODUCT USE ISSUE 629
80 ERYTHEMA 628
81 HYPOAESTHESIA 627
82 DRY SKIN 621
83 SINUSITIS 616
84 TOXICITY TO VARIOUS AGENTS 615
85 ILLNESS 611
86 EPISTAXIS 610
87 INJECTION SITE PAIN 605
88 DRUG HYPERSENSITIVITY 588
89 SEPSIS 588
90 BRADYCARDIA 583
91 DYSPEPSIA 583
92 HYPERSENSITIVITY 578
93 HOT FLUSH 576
94 NEUROPATHY PERIPHERAL 574
95 INCORRECT DOSE ADMINISTERED 571
96 INFLUENZA 570
97 WHITE BLOOD CELL COUNT DECREASED 570
98 HYPERHIDROSIS 561
99 PARAESTHESIA 556
100 BALANCE DISORDER 551
101 BLOOD PRESSURE DECREASED 540
102 HOSPITALISATION 537
103 INFECTION 537
104 ARRHYTHMIA 528
105 GASTROOESOPHAGEAL REFLUX DISEASE 525
106 BLOOD CREATININE INCREASED 511
107 ABDOMINAL DISTENSION 502
108 VISUAL IMPAIRMENT 500
109 OXYGEN SATURATION DECREASED 497
110 DYSPNOEA EXERTIONAL 496
111 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 495
112 OROPHARYNGEAL PAIN 490
113 BRONCHITIS 485
114 RHINORRHOEA 474
115 TACHYCARDIA 460
116 FLUSHING 457
117 EYE IRRITATION 455
118 HALLUCINATION 453
119 URTICARIA 453
120 CHILLS 452
121 FLUID RETENTION 450
122 PRODUCTIVE COUGH 450
123 RENAL IMPAIRMENT 444
124 DRY MOUTH 443
125 CARDIAC ARREST 441
126 JOINT SWELLING 440
127 PLEURAL EFFUSION 440
128 ASTHMA 439
129 DYSPHAGIA 437
130 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 422
131 ARTHRITIS 419
132 GENERAL PHYSICAL HEALTH DETERIORATION 416
133 DIABETES MELLITUS 413
134 THROMBOSIS 402
135 HAEMORRHAGE 399
136 GASTROINTESTINAL DISORDER 396
137 THROMBOCYTOPENIA 393
138 CORONARY ARTERY DISEASE 388
139 PRODUCT SUBSTITUTION ISSUE 378
140 SUSPECTED SUICIDE 375
141 DRUG DOSE OMISSION 373
142 SWELLING 372
143 SLEEP DISORDER 371
144 PRODUCT QUALITY ISSUE 370
145 INTENTIONAL PRODUCT MISUSE 369
146 THERAPY INTERRUPTED 368
147 SKIN EXFOLIATION 367
148 RESPIRATORY FAILURE 358
149 OVERDOSE 354
150 UNEVALUABLE EVENT 352
151 HEART RATE DECREASED 350
152 DYSPHONIA 346
153 DRUG INTOLERANCE 345
154 PULMONARY EMBOLISM 342
155 HYPOKALAEMIA 337
156 HYPERKALAEMIA 330
157 HYPONATRAEMIA 329
158 PULMONARY OEDEMA 327
159 PSORIASIS 324
160 UPPER RESPIRATORY TRACT INFECTION 324
161 DRY EYE 323
162 NEUTROPENIA 323
163 OEDEMA 322
164 NASAL CONGESTION 321
165 STRESS 321
166 THROAT IRRITATION 320
167 FLATULENCE 319
168 ADVERSE DRUG REACTION 316
169 CATARACT 316
170 SEIZURE 315
171 STOMATITIS 313
172 RENAL FAILURE ACUTE 312
173 INTENTIONAL PRODUCT USE ISSUE 308
174 ACUTE MYOCARDIAL INFARCTION 299
175 DYSGEUSIA 299
176 ANGINA PECTORIS 297
177 SEASONAL ALLERGY 291
178 MIGRAINE 290
179 MOBILITY DECREASED 290
180 NECK PAIN 283
181 HEART RATE IRREGULAR 282
182 RHABDOMYOLYSIS 281
183 BLOOD POTASSIUM DECREASED 277
184 OCULAR HYPERAEMIA 276
185 DISEASE PROGRESSION 275
186 VERTIGO 275
187 ADVERSE EVENT 272
188 BLOOD CHOLESTEROL INCREASED 271
189 POLLAKIURIA 271
190 RENAL DISORDER 271
191 HYPOXIA 270
192 HERPES ZOSTER 269
193 MUSCULOSKELETAL STIFFNESS 269
194 LETHARGY 267
195 WHEEZING 266
196 BURNING SENSATION 265
197 BONE PAIN 264
198 CELLULITIS 264
199 HEPATIC ENZYME INCREASED 264
200 RHEUMATOID ARTHRITIS 262
201 SURGERY 261
202 BLOOD PRESSURE ABNORMAL 259
203 DISCOMFORT 259
204 DEEP VEIN THROMBOSIS 257
205 BLISTER 255
206 AMNESIA 254
207 RASH PRURITIC 254
208 NERVOUSNESS 252
209 SKIN DISCOLOURATION 252
210 NEPHROLITHIASIS 251
211 PRODUCT DOSE OMISSION 250
212 TREATMENT NONCOMPLIANCE 248
213 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 247
214 INFLUENZA LIKE ILLNESS 246
215 MALIGNANT NEOPLASM PROGRESSION 244
216 HEAD INJURY 243
217 THERAPY NON-RESPONDER 243
218 INTERNATIONAL NORMALISED RATIO INCREASED 241
219 HYPOACUSIS 236
220 END STAGE RENAL DISEASE 235
221 SPEECH DISORDER 235
222 RED BLOOD CELL COUNT DECREASED 229
223 CARDIOGENIC SHOCK 228
224 TRANSIENT ISCHAEMIC ATTACK 228
225 HAEMOPTYSIS 225
226 INJECTION SITE ERYTHEMA 225
227 OSTEOARTHRITIS 225
228 ALANINE AMINOTRANSFERASE INCREASED 224
229 LACRIMATION INCREASED 224
230 BLOOD PRESSURE FLUCTUATION 223
231 GOUT 223
232 DERMATITIS ATOPIC 222
233 INJURY 222
234 LUNG DISORDER 221
235 PRODUCT DOSE OMISSION IN ERROR 221
236 EMOTIONAL DISTRESS 220
237 PULMONARY HYPERTENSION 219
238 CORONARY ARTERY OCCLUSION 218
239 SWELLING FACE 218
240 ASPARTATE AMINOTRANSFERASE INCREASED 217
241 FEELING HOT 217
242 HAEMATOCHEZIA 217
243 PANCYTOPENIA 217
244 TINNITUS 217
245 AGITATION 216
246 ECZEMA 216
247 RENAL INJURY 216
248 HAEMATURIA 212
249 COMPLETED SUICIDE 211
250 DISTURBANCE IN ATTENTION 209
251 MENTAL STATUS CHANGES 208
252 FULL BLOOD COUNT DECREASED 207
253 DYSURIA 206
254 RECTAL HAEMORRHAGE 206
255 MUSCULOSKELETAL PAIN 205
256 INFUSION SITE PAIN 202
257 INTENTIONAL DOSE OMISSION 202
258 HYPERSOMNIA 201
259 LIMB INJURY 200
260 URINARY RETENTION 200
261 VENTRICULAR TACHYCARDIA 200
262 CYSTITIS 198
263 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 198
264 ARTHROPATHY 196
265 NO ADVERSE EVENT 196
266 CEREBRAL HAEMORRHAGE 194
267 PLASMA CELL MYELOMA 194
268 EJECTION FRACTION DECREASED 193
269 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 192
270 BLOOD GLUCOSE DECREASED 191
271 WHITE BLOOD CELL COUNT INCREASED 191
272 DIVERTICULITIS 188
273 GAIT INABILITY 188
274 HYPOGLYCAEMIA 188
275 EYE SWELLING 187
276 OSTEOPOROSIS 186
277 URINARY INCONTINENCE 185
278 COGNITIVE DISORDER 183
279 STAPHYLOCOCCAL INFECTION 182
280 SLEEP APNOEA SYNDROME 181
281 PHOTOPHOBIA 180
282 CHOLELITHIASIS 179
283 HIP FRACTURE 179
284 NEOPLASM MALIGNANT 179
285 PANCREATITIS 179
286 TYPE 2 DIABETES MELLITUS 179
287 DEPRESSED MOOD 178
288 LIMB DISCOMFORT 178
289 MITRAL VALVE INCOMPETENCE 178
290 ACUTE RESPIRATORY FAILURE 177
291 DISORIENTATION 177
292 ELECTROCARDIOGRAM QT PROLONGED 177
293 HIATUS HERNIA 177
294 SKIN ULCER 176
295 DEVICE ISSUE 175
296 ORTHOSTATIC HYPOTENSION 174
297 RESTLESSNESS 174
298 VIRAL INFECTION 174
299 BLOOD SODIUM DECREASED 173
300 ILL-DEFINED DISORDER 172
301 THERAPEUTIC RESPONSE DECREASED 172
302 TASTE DISORDER 171
303 EYE PRURITUS 170
304 VENTRICULAR EXTRASYSTOLES 170
305 PRESYNCOPE 169
306 PERICARDIAL EFFUSION 168
307 METABOLIC ACIDOSIS 167
308 PAIN IN JAW 165
309 HAEMATOCRIT DECREASED 164
310 RASH MACULAR 164
311 BLOOD POTASSIUM INCREASED 163
312 SINUS BRADYCARDIA 163
313 FEBRILE NEUTROPENIA 162
314 LEUKOPENIA 162
315 THERAPEUTIC RESPONSE UNEXPECTED 162
316 LABORATORY TEST ABNORMAL 161
317 SEPTIC SHOCK 161
318 HYPERGLYCAEMIA 160
319 FUNGAL INFECTION 159
320 UNDERDOSE 159
321 HYPOTHYROIDISM 158
322 INJECTION SITE BRUISING 158
323 SINUS DISORDER 158
324 DELIRIUM 157
325 GASTRITIS 157
326 IMPAIRED HEALING 157
327 LOCALISED INFECTION 156
328 NIGHT SWEATS 156
329 RESPIRATORY TRACT INFECTION 156
330 THERAPY CESSATION 156
331 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 155
332 HAEMATOMA 154
333 HYPERLIPIDAEMIA 154
334 LACTIC ACIDOSIS 154
335 PRODUCT ADMINISTRATION INTERRUPTED 154
336 AGEUSIA 153
337 BLOOD UREA INCREASED 153
338 DISEASE RECURRENCE 153
339 DYSARTHRIA 153
340 INJECTION SITE PRURITUS 153
341 DEMENTIA 152
342 ATRIAL FLUTTER 151
343 RETCHING 151
344 UNRESPONSIVE TO STIMULI 149
345 ASCITES 148
346 INFUSION RELATED REACTION 148
347 FEELING COLD 147
348 INJECTION SITE SWELLING 147
349 SUICIDAL IDEATION 147
350 ENCEPHALOPATHY 146
351 HYPOMAGNESAEMIA 146
352 MELAENA 146
353 MEDICATION ERROR 145
354 ORAL PAIN 145
355 NEPHROGENIC ANAEMIA 144
356 SUICIDE ATTEMPT 142
357 ERUCTATION 140
358 ACCIDENTAL EXPOSURE TO PRODUCT 139
359 RASH ERYTHEMATOUS 139
360 HEPATIC STEATOSIS 138
361 HYPERTENSIVE CRISIS 138
362 INJECTION SITE HAEMORRHAGE 138
363 NIGHTMARE 138
364 RIB FRACTURE 138
365 DYSSTASIA 137
366 DEVICE MALFUNCTION 136
367 HALLUCINATION, VISUAL 136
368 INFUSION SITE ERYTHEMA 136
369 LIVER DISORDER 136
370 CARDIOVASCULAR DISORDER 135
371 COMA 135
372 INFLAMMATION 135
373 BLOOD PRESSURE INADEQUATELY CONTROLLED 134
374 MENTAL DISORDER 134
375 APHASIA 133
376 CARDIO-RESPIRATORY ARREST 132
377 CHROMATURIA 131
378 INTENTIONAL OVERDOSE 131
379 BODY HEIGHT DECREASED 130
380 FAECES DISCOLOURED 130
381 GLOMERULAR FILTRATION RATE DECREASED 130
382 ANGIOEDEMA 129
383 COLITIS 128
384 HEAD DISCOMFORT 128
385 TRICUSPID VALVE INCOMPETENCE 128
386 FOETAL EXPOSURE DURING PREGNANCY 127
387 GASTROENTERITIS VIRAL 127
388 SKIN FISSURES 127
389 THERAPEUTIC PRODUCT EFFECT DECREASED 127
390 NEUTROPHIL COUNT DECREASED 126
391 PANIC ATTACK 126
392 SNEEZING 126
393 JOINT INJURY 125
394 SWOLLEN TONGUE 125
395 BRAIN FOG 124
396 HYPOPHAGIA 123
397 INTESTINAL OBSTRUCTION 123
398 SKIN HAEMORRHAGE 123
399 TOOTH DISORDER 123
400 INTERVERTEBRAL DISC PROTRUSION 122
401 SPINAL FRACTURE 122
402 FEAR 121
403 BLOOD URINE PRESENT 120
404 CARDIOMYOPATHY 120
405 EAR INFECTION 120
406 INSURANCE ISSUE 120
407 OCULAR DISCOMFORT 120
408 ROAD TRAFFIC ACCIDENT 120
409 DIPLOPIA 119
410 LEUKOCYTOSIS 119
411 LIVER FUNCTION TEST ABNORMAL 119
412 LYMPHADENOPATHY 118
413 RESPIRATORY TRACT CONGESTION 118
414 THERAPEUTIC RESPONSE SHORTENED 118
415 IRRITABILITY 117
416 NEOPLASM PROGRESSION 117
417 ANHEDONIA 116
418 DEPRESSED LEVEL OF CONSCIOUSNESS 116
419 HAEMORRHOIDS 116
420 HYPOCALCAEMIA 116
421 POOR QUALITY SLEEP 116
422 RESTLESS LEGS SYNDROME 116
423 ACCIDENTAL OVERDOSE 115
424 ACNE 115
425 BLOOD ALKALINE PHOSPHATASE INCREASED 115
426 DIZZINESS POSTURAL 115
427 HERNIA 115
428 PERIPHERAL COLDNESS 115
429 PSORIATIC ARTHROPATHY 115
430 ABNORMAL DREAMS 114
431 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 114
432 BLOOD CREATINE PHOSPHOKINASE INCREASED 113
433 EXPOSURE DURING PREGNANCY 113
434 SCIATICA 113
435 FEEDING DISORDER 112
436 LIVER FUNCTION TEST INCREASED 112
437 MUSCULOSKELETAL DISCOMFORT 112
438 OBESITY 112
439 PROSTATIC SPECIFIC ANTIGEN INCREASED 112
440 SKIN CANCER 112
441 SKIN LESION 112
442 ANAPHYLACTIC REACTION 111
443 BRASH SYNDROME 111
444 BREAST CANCER 111
445 CONTRAINDICATED PRODUCT ADMINISTERED 111
446 TUBULOINTERSTITIAL NEPHRITIS 111
447 ARTERIOSCLEROSIS CORONARY ARTERY 110
448 BACK DISORDER 110
449 C-REACTIVE PROTEIN INCREASED 110
450 DEAFNESS 110
451 EYE DISORDER 110
452 VENTRICULAR FIBRILLATION 110
453 BLOOD TRIGLYCERIDES INCREASED 109
454 DRUG-INDUCED LIVER INJURY 109
455 HYPERCHOLESTEROLAEMIA 109
456 MULTIPLE ORGAN DYSFUNCTION SYNDROME 109
457 UPPER GASTROINTESTINAL HAEMORRHAGE 109
458 CIRCULATORY COLLAPSE 108
459 FOOT FRACTURE 108
460 SKIN DISORDER 108
461 STENT PLACEMENT 108
462 WEIGHT FLUCTUATION 108
463 PULMONARY CONGESTION 107
464 SINUS TACHYCARDIA 107
465 INFUSION SITE SWELLING 106
466 OSTEOPENIA 106
467 RESPIRATORY DISORDER 106
468 SUPRAVENTRICULAR TACHYCARDIA 106
469 DYSKINESIA 105
470 LIP SWELLING 105
471 LUNG NEOPLASM MALIGNANT 105
472 BLOOD PRESSURE SYSTOLIC INCREASED 104
473 GASTRIC ULCER 104
474 INJECTION SITE REACTION 104
475 KIDNEY INFECTION 104
476 MULTIPLE SCLEROSIS RELAPSE 104
477 THYROID DISORDER 104
478 BLINDNESS 103
479 MIDDLE INSOMNIA 103
480 NOCTURIA 103
481 PNEUMONITIS 103
482 MUSCULOSKELETAL CHEST PAIN 102
483 PARKINSON^S DISEASE 102
484 RESPIRATORY DISTRESS 102
485 ATRIOVENTRICULAR BLOCK 101
486 CONVULSION 101
487 EATING DISORDER 101
488 ANGINA UNSTABLE 100
489 CLOSTRIDIUM DIFFICILE INFECTION 100
490 IMPAIRED GASTRIC EMPTYING 100
491 LEFT VENTRICULAR DYSFUNCTION 100
492 PULMONARY MASS 100
493 SKIN BURNING SENSATION 100
494 BLOOD BILIRUBIN INCREASED 99
495 INCREASED TENDENCY TO BRUISE 99
496 POST PROCEDURAL COMPLICATION 99
497 PRODUCT AVAILABILITY ISSUE 99
498 BLOOD MAGNESIUM DECREASED 98
499 CARDIOMEGALY 98
500 ERECTILE DYSFUNCTION 98
501 MOVEMENT DISORDER 98
502 PRODUCT USE COMPLAINT 98
503 VITAMIN D DEFICIENCY 98
504 NEURALGIA 97
505 WOUND 97
506 BASAL CELL CARCINOMA 96
507 COAGULOPATHY 96
508 GASTRIC DISORDER 96
509 HEPATIC FAILURE 96
510 IRRITABLE BOWEL SYNDROME 96
511 HAEMATEMESIS 95
512 INJECTION SITE MASS 95
513 JOINT STIFFNESS 95
514 PALLOR 94
515 PRODUCT ADMINISTRATION ERROR 94
516 DIVERTICULUM INTESTINAL 93
517 EXTRA DOSE ADMINISTERED 93
518 INTERSTITIAL LUNG DISEASE 93
519 PRESCRIBED UNDERDOSE 93
520 COLD SWEAT 92
521 EAR PAIN 92
522 DECREASED ACTIVITY 91
523 EXPOSURE VIA SKIN CONTACT 91
524 PROSTATE CANCER 91
525 UPPER LIMB FRACTURE 91
526 AGGRESSION 90
527 ECONOMIC PROBLEM 90
528 GLOSSODYNIA 90
529 CANDIDA INFECTION 89
530 CARDIAC FAILURE ACUTE 89
531 EXTRASYSTOLES 89
532 GLAUCOMA 89
533 KNEE ARTHROPLASTY 89
534 MENTAL IMPAIRMENT 89
535 ARTERIOSCLEROSIS 88
536 DRUG EFFECT DECREASED 88
537 PANCREATITIS ACUTE 88
538 SINUS CONGESTION 88
539 THIRST 88
540 TOOTHACHE 88
541 BLOOD CALCIUM DECREASED 87
542 CEREBRAL INFARCTION 87
543 DEVICE LEAKAGE 87
544 MATERNAL EXPOSURE DURING PREGNANCY 87
545 MULTIPLE ALLERGIES 87
546 MYELODYSPLASTIC SYNDROME 87
547 TRANSAMINASES INCREASED 87
548 ATRIOVENTRICULAR BLOCK COMPLETE 86
549 BLOOD IRON DECREASED 86
550 CARDIAC FLUTTER 86
551 CHOKING 86
552 DELUSION 86
553 IMPAIRED QUALITY OF LIFE 86
554 PRE-EXISTING CONDITION IMPROVED 86
555 RENAL CYST 86
556 SKIN LACERATION 86
557 GINGIVAL BLEEDING 85
558 GLYCOSYLATED HAEMOGLOBIN INCREASED 85
559 JOINT DISLOCATION 85
560 ABNORMAL BEHAVIOUR 84
561 PNEUMONIA ASPIRATION 84
562 PRODUCT STORAGE ERROR 84
563 SHOCK 84
564 SMALL INTESTINAL OBSTRUCTION 84
565 ARTERIAL OCCLUSIVE DISEASE 83
566 HAEMORRHAGE INTRACRANIAL 83
567 INTERNAL HAEMORRHAGE 83
568 LOWER GASTROINTESTINAL HAEMORRHAGE 83
569 PRODUCT DISTRIBUTION ISSUE 83
570 BLOOD GLUCOSE ABNORMAL 82
571 CARPAL TUNNEL SYNDROME 82
572 CORONARY ARTERY STENOSIS 82
573 EYE HAEMORRHAGE 82
574 GALLBLADDER DISORDER 82
575 PULMONARY FIBROSIS 82
576 BONE DISORDER 81
577 CARDIAC MURMUR 81
578 GROIN PAIN 81
579 ORAL CANDIDIASIS 81
580 HEPATIC FUNCTION ABNORMAL 80
581 HOSPICE CARE 80
582 INFUSION SITE HAEMORRHAGE 80
583 MULTI-ORGAN FAILURE 80
584 TOOTH INFECTION 80
585 ULCER 80
586 HEART RATE ABNORMAL 79
587 HEPATIC CIRRHOSIS 79
588 HYPERVOLAEMIA 79
589 INCREASED APPETITE 79
590 RESPIRATORY ARREST 79
591 CHOLECYSTITIS 78
592 DERMATITIS CONTACT 78
593 ELECTROLYTE IMBALANCE 78
594 EYE DISCHARGE 78
595 FULL BLOOD COUNT ABNORMAL 78
596 LOWER LIMB FRACTURE 78
597 PRODUCT PRESCRIBING ISSUE 78
598 SPINAL OSTEOARTHRITIS 78
599 TORSADE DE POINTES 78
600 DIABETES MELLITUS INADEQUATE CONTROL 77
601 DRUG ABUSE 77
602 FREQUENT BOWEL MOVEMENTS 77
603 TACHYPNOEA 77
604 UPPER-AIRWAY COUGH SYNDROME 77
605 ABDOMINAL PAIN LOWER 76
606 BACTERIAL INFECTION 76
607 BLOOD COUNT ABNORMAL 76
608 PAIN OF SKIN 76
609 TACHYARRHYTHMIA 76
610 APATHY 75
611 ISCHAEMIC STROKE 75
612 OROPHARYNGEAL DISCOMFORT 75
613 ANKLE FRACTURE 74
614 BEDRIDDEN 74
615 DEVICE OCCLUSION 74
616 FEMUR FRACTURE 74
617 GAMMA-GLUTAMYLTRANSFERASE INCREASED 74
618 MALNUTRITION 74
619 PLATELET COUNT INCREASED 74
620 PULMONARY ARTERIAL HYPERTENSION 74
621 DERMATITIS 73
622 FIBROMYALGIA 73
623 HIP ARTHROPLASTY 73
624 MUSCULOSKELETAL DISORDER 73
625 PSYCHOTIC DISORDER 73
626 RENAL FAILURE CHRONIC 73
627 SECRETION DISCHARGE 73
628 VISUAL ACUITY REDUCED 73
629 BLOOD TEST ABNORMAL 72
630 PELVIC FRACTURE 72
631 PROCEDURAL PAIN 72
632 SCAR 72
633 ANURIA 71
634 ESSENTIAL HYPERTENSION 71
635 FOREIGN BODY SENSATION IN EYES 71
636 MYOCARDIAL ISCHAEMIA 71
637 PHARMACEUTICAL PRODUCT COMPLAINT 71
638 PROTEINURIA 71
639 SCRATCH 71
640 THINKING ABNORMAL 71
641 THROAT TIGHTNESS 71
642 INJECTION SITE RASH 70
643 MULTIPLE SCLEROSIS 70
644 POLYNEUROPATHY 70
645 SCAB 70
646 UROSEPSIS 70
647 DRUG LEVEL INCREASED 69
648 EYE INFECTION 69
649 HEPATIC CYST 69
650 LYMPHOCYTE COUNT DECREASED 69
651 QUALITY OF LIFE DECREASED 69
652 DIALYSIS 68
653 DIASTOLIC DYSFUNCTION 68
654 ELECTROCARDIOGRAM ABNORMAL 68
655 FEELING JITTERY 68
656 GASTROENTERITIS 68
657 JAUNDICE 68
658 METASTASES TO LIVER 68
659 MOOD SWINGS 68
660 MUSCLE TWITCHING 68
661 OSTEOMYELITIS 68
662 PRODUCT PHYSICAL ISSUE 68
663 PRURITUS GENERALISED 68
664 RENAL TUBULAR NECROSIS 68
665 SARS-COV-2 TEST POSITIVE 68
666 TREATMENT FAILURE 68
667 ATRIOVENTRICULAR BLOCK FIRST DEGREE 67
668 BODY TEMPERATURE INCREASED 67
669 CRYING 67
670 DRUG EFFECT LESS THAN EXPECTED 67
671 HEMIPARESIS 67
672 PNEUMOTHORAX 67
673 THERAPY PARTIAL RESPONDER 67
674 WRIST FRACTURE 67
675 APHONIA 66
676 BUNDLE BRANCH BLOCK LEFT 66
677 CARDIAC OPERATION 66
678 INITIAL INSOMNIA 66
679 MUSCLE ATROPHY 66
680 OESOPHAGITIS 66
681 ROTATOR CUFF SYNDROME 66
682 STEVENS-JOHNSON SYNDROME 66
683 SYSTEMIC LUPUS ERYTHEMATOSUS 66
684 ANTI-NEUTROPHIL CYTOPLASMIC ANTIBODY POSITIVE VASCULITIS 65
685 BACK INJURY 65
686 COVID-19 PNEUMONIA 65
687 IMMUNODEFICIENCY 65
688 MACULAR DEGENERATION 65
689 PROTHROMBIN TIME PROLONGED 65
690 SKIN IRRITATION 65
691 SLUGGISHNESS 65
692 SUBDURAL HAEMATOMA 65
693 EYELID PAIN 64
694 HEREDITARY ANGIOEDEMA 64
695 HYPERPARATHYROIDISM SECONDARY 64
696 HYPOKINESIA 64
697 INCONTINENCE 64
698 MICTURITION URGENCY 64
699 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 64
700 PULMONARY THROMBOSIS 64
701 RASH GENERALISED 64
702 RASH PAPULAR 64
703 VITAMIN D DECREASED 64
704 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 64
705 AORTIC ARTERIOSCLEROSIS 63
706 BLOOD LACTATE DEHYDROGENASE INCREASED 63
707 DEVICE DIFFICULT TO USE 63
708 EAR DISCOMFORT 63
709 EMPHYSEMA 63
710 HAEMORRHAGIC ANAEMIA 63
711 HYPERURICAEMIA 63
712 HYPOAESTHESIA ORAL 63
713 MOOD ALTERED 63
714 ORAL HERPES 63
715 PHARYNGEAL SWELLING 63
716 SPLENOMEGALY 63
717 DRUG WITHDRAWAL SYNDROME 62
718 FLUID OVERLOAD 62
719 HALLUCINATION, AUDITORY 62
720 HYPERTHYROIDISM 62
721 LIVER INJURY 62
722 PHOTOSENSITIVITY REACTION 62
723 REBOUND ACID HYPERSECRETION 62
724 SPINAL OPERATION 62
725 TROPONIN INCREASED 62
726 CLOSTRIDIUM DIFFICILE COLITIS 61
727 EMOTIONAL DISORDER 61
728 ESCHERICHIA INFECTION 61
729 GASTROINTESTINAL PAIN 61
730 GENERALISED OEDEMA 61
731 GLUCOSE TOLERANCE IMPAIRED 61
732 HYPOVOLAEMIA 61
733 IRON DEFICIENCY ANAEMIA 61
734 NEEDLE ISSUE 61
735 ORAL DISCOMFORT 61
736 POSTOPERATIVE WOUND INFECTION 61
737 ACUTE RESPIRATORY DISTRESS SYNDROME 60
738 CONJUNCTIVITIS 60
739 DISABILITY 60
740 HYPOTHERMIA 60
741 INTERVERTEBRAL DISC DEGENERATION 60
742 LUNG INFILTRATION 60
743 PRODUCT PRESCRIBING ERROR 60
744 TENDERNESS 60
745 ANGER 59
746 ANOREXIA 59
747 AORTIC ANEURYSM 59
748 AORTIC VALVE INCOMPETENCE 59
749 AORTIC VALVE STENOSIS 59
750 ATELECTASIS 59
751 BLOOD CALCIUM INCREASED 59
752 BLOOD CHOLESTEROL ABNORMAL 59
753 CARDIAC PACEMAKER INSERTION 59
754 DEVICE USE ISSUE 59
755 HAEMARTHROSIS 59
756 IMMUNE SYSTEM DISORDER 59
757 METASTASES TO BONE 59
758 MUSCLE TIGHTNESS 59
759 NEPHROPATHY 59
760 PETECHIAE 59
761 POST PROCEDURAL HAEMORRHAGE 59
762 SUBARACHNOID HAEMORRHAGE 59
763 BENIGN PROSTATIC HYPERPLASIA 58
764 CYTOKINE RELEASE SYNDROME 58
765 DEVICE DISLOCATION 58
766 FLANK PAIN 58
767 HEPATOMEGALY 58
768 HYPERCALCAEMIA 58
769 LIGAMENT SPRAIN 58
770 LOWER RESPIRATORY TRACT INFECTION 58
771 ACTIVITIES OF DAILY LIVING IMPAIRED 57
772 ACUTE CORONARY SYNDROME 57
773 ANAL INCONTINENCE 57
774 BRONCHOSPASM 57
775 CARDIAC FAILURE CHRONIC 57
776 CYANOSIS 57
777 DIABETIC NEUROPATHY 57
778 FAECES SOFT 57
779 SPUTUM DISCOLOURED 57
780 VAGINAL HAEMORRHAGE 57
781 WRONG TECHNIQUE IN DRUG USAGE PROCESS 57
782 BLOOD THYROID STIMULATING HORMONE INCREASED 56
783 BOWEL MOVEMENT IRREGULARITY 56
784 BURSITIS 56
785 CARDIAC VALVE DISEASE 56
786 HAEMOGLOBIN INCREASED 56
787 HEPATITIS 56
788 JOINT RANGE OF MOTION DECREASED 56
789 NERVOUS SYSTEM DISORDER 56
790 PRODUCT DISPENSING ERROR 56
791 SOMNAMBULISM 56
792 BLADDER DISORDER 55
793 CHOKING SENSATION 55
794 FACIAL PAIN 55
795 INFUSION SITE DISCHARGE 55
796 SKIN INFECTION 55
797 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 54
798 DEVICE FAILURE 54
799 DRUG TOXICITY 54
800 MUCOSAL INFLAMMATION 54
801 RECALLED PRODUCT ADMINISTERED 54
802 TEMPERATURE INTOLERANCE 54
803 VITREOUS FLOATERS 54
804 COELIAC DISEASE 53
805 COORDINATION ABNORMAL 53
806 CYTOPENIA 53
807 DEVICE RELATED INFECTION 53
808 HEPATOTOXICITY 53
809 HYDRONEPHROSIS 53
810 LUNG INFECTION 53
811 WITHDRAWAL SYNDROME 53
812 CHRONIC GASTRITIS 52
813 COLITIS ULCERATIVE 52
814 MASS 52
815 NASAL DRYNESS 52
816 NERVE INJURY 52
817 PARALYSIS 52
818 PERIPHERAL VASCULAR DISORDER 52
819 RALES 52
820 RENAL PAIN 52
821 URINE OUTPUT DECREASED 52
822 VENTRICULAR HYPOKINESIA 52
823 ABASIA 51
824 DRUG DEPENDENCE 51
825 INFLAMMATORY MARKER INCREASED 51
826 MOUTH HAEMORRHAGE 51
827 RESPIRATORY SYNCYTIAL VIRUS INFECTION 51
828 SKIN SWELLING 51
829 SPINAL DISORDER 51
830 VENTRICULAR ARRHYTHMIA 51
831 CATHETERISATION CARDIAC 50
832 CHOLECYSTECTOMY 50
833 CROHN^S DISEASE 50
834 FRACTURE 50
835 GASTROINTESTINAL INFECTION 50
836 ILEUS 50
837 LARYNGITIS 50
838 SENSORY DISTURBANCE 50
839 SKIN ABRASION 50
840 ACUTE HEPATIC FAILURE 49
841 AORTIC STENOSIS 49
842 ARTERIAL HAEMORRHAGE 49
843 BLOOD GLUCOSE FLUCTUATION 49
844 FACE OEDEMA 49
845 FAECALOMA 49
846 HIGH DENSITY LIPOPROTEIN DECREASED 49
847 MALIGNANT MELANOMA 49
848 POLYP 49
849 PROTEIN URINE PRESENT 49
850 TRANSFUSION 49
851 ARTHROPOD BITE 48
852 CAROTID ARTERY STENOSIS 48
853 COLITIS ISCHAEMIC 48
854 COLON CANCER 48
855 DIABETIC KETOACIDOSIS 48
856 DRUG EFFECT INCOMPLETE 48
857 EXERCISE TOLERANCE DECREASED 48
858 HUNGER 48
859 OBSTRUCTIVE SLEEP APNOEA SYNDROME 48
860 PARANOIA 48
861 PERIORBITAL PAIN 48
862 PHARYNGEAL OEDEMA 48
863 PRODUCT TASTE ABNORMAL 48
864 TOOTH ABSCESS 48
865 TOOTH FRACTURE 48
866 DECUBITUS ULCER 47
867 EPILEPSY 47
868 INJECTION SITE URTICARIA 47
869 LYMPHOEDEMA 47
870 NEUTROPHIL COUNT INCREASED 47
871 ONYCHOCLASIS 47
872 PNEUMONIA BACTERIAL 47
873 RASH MACULO-PAPULAR 47
874 RENAL FUNCTION TEST ABNORMAL 47
875 SINUS HEADACHE 47
876 WALKING AID USER 47
877 ATRIOVENTRICULAR BLOCK SECOND DEGREE 46
878 DENTAL CARIES 46
879 DIVERTICULUM 46
880 HAEMORRHAGIC STROKE 46
881 INFUSION SITE BRUISING 46
882 LISTLESS 46
883 OXYGEN CONSUMPTION INCREASED 46
884 PARAESTHESIA ORAL 46
885 PLATELET COUNT ABNORMAL 46
886 SNORING 46
887 SWELLING OF EYELID 46
888 ANEURYSM 45
889 APLASTIC ANAEMIA 45
890 APPETITE DISORDER 45
891 CEREBRAL ISCHAEMIA 45
892 CORONARY ARTERIAL STENT INSERTION 45
893 DERMATITIS ALLERGIC 45
894 EXPIRED PRODUCT ADMINISTERED 45
895 GASTRIC HAEMORRHAGE 45
896 INTENTIONAL DRUG MISUSE 45
897 RESPIRATION ABNORMAL 45
898 ASPIRATION 44
899 BREATH SOUNDS ABNORMAL 44
900 COMPLICATION ASSOCIATED WITH DEVICE 44
901 DRUG ERUPTION 44
902 GASTRIC ULCER HAEMORRHAGE 44
903 HAEMORRHOIDAL HAEMORRHAGE 44
904 INCORRECT PRODUCT ADMINISTRATION DURATION 44
905 INFUSION SITE PRURITUS 44
906 SCOLIOSIS 44
907 SHOCK HAEMORRHAGIC 44
908 TENDON RUPTURE 44
909 BUNDLE BRANCH BLOCK RIGHT 43
910 CONCUSSION 43
911 DEVICE INFUSION ISSUE 43
912 DRUG ADMINISTRATION ERROR 43
913 DRY THROAT 43
914 KNEE OPERATION 43
915 LEFT VENTRICULAR HYPERTROPHY 43
916 LOW DENSITY LIPOPROTEIN INCREASED 43
917 MUSCLE SPASTICITY 43
918 NAIL DISORDER 43
919 POST PROCEDURAL INFECTION 43
920 RESPIRATORY DEPRESSION 43
921 RIGHT VENTRICULAR FAILURE 43
922 SPINAL PAIN 43
923 THERAPEUTIC RESPONSE UNEXPECTED WITH DRUG SUBSTITUTION 43
924 ACIDOSIS 42
925 BLINDNESS UNILATERAL 42
926 CYST 42
927 ECCHYMOSIS 42
928 FOOT DEFORMITY 42
929 HYPOTONIA 42
930 INABILITY TO AFFORD MEDICATION 42
931 LEFT VENTRICULAR FAILURE 42
932 SEDATION 42
933 TOOTH EXTRACTION 42
934 AUTOIMMUNE DISORDER 41
935 BLOOD ALBUMIN DECREASED 41
936 BLOOD PRESSURE SYSTOLIC DECREASED 41
937 BRAIN OEDEMA 41
938 BREAST CANCER FEMALE 41
939 CHOLESTASIS 41
940 CORONARY ARTERY BYPASS 41
941 GASTROINTESTINAL MOTILITY DISORDER 41
942 HAND FRACTURE 41
943 ISCHAEMIC CARDIOMYOPATHY 41
944 METASTASES TO LUNG 41
945 OSTEONECROSIS 41
946 PERIPHERAL ARTERIAL OCCLUSIVE DISEASE 41
947 PHARYNGITIS 41
948 POLYURIA 41
949 PROSTATOMEGALY 41
950 SENSITIVE SKIN 41
951 SPINAL COMPRESSION FRACTURE 41
952 VASCULITIS 41
953 AGRANULOCYTOSIS 40
954 BACTERAEMIA 40
955 DRUG RESISTANCE 40
956 EXOSTOSIS 40
957 FOOD ALLERGY 40
958 HYPERKERATOSIS 40
959 INJECTION SITE IRRITATION 40
960 INTERNATIONAL NORMALISED RATIO DECREASED 40
961 LARGE INTESTINE POLYP 40
962 NERVE COMPRESSION 40
963 ORAL MUCOSAL BLISTERING 40
964 ORTHOPNOEA 40
965 OVERWEIGHT 40
966 PRODUCT PREPARATION ERROR 40
967 PRODUCT RESIDUE PRESENT 40
968 PSEUDOMONAS INFECTION 40
969 RENAL CELL CARCINOMA 40
970 SKIN ATROPHY 40
971 SQUAMOUS CELL CARCINOMA 40
972 WHITE BLOOD CELL COUNT ABNORMAL 40
973 WOUND DEHISCENCE 40
974 ACCIDENT 39
975 ACUTE MYELOID LEUKAEMIA 39
976 DEVICE BREAKAGE 39
977 DEVICE USE ERROR 39
978 HAEMODYNAMIC INSTABILITY 39
979 HAEMOGLOBIN ABNORMAL 39
980 HALLUCINATIONS, MIXED 39
981 IMPAIRED DRIVING ABILITY 39
982 INFUSION SITE EXTRAVASATION 39
983 MULTIPLE FRACTURES 39
984 OSTEONECROSIS OF JAW 39
985 PERIORBITAL SWELLING 39
986 PERITONITIS 39
987 POOR VENOUS ACCESS 39
988 RHINITIS ALLERGIC 39
989 THYROID MASS 39
990 URINE ODOUR ABNORMAL 39
991 VARICOSE VEIN 39
992 VASCULAR DEVICE INFECTION 39
993 BLADDER CANCER 38
994 BONE DENSITY DECREASED 38
995 ERYTHEMA OF EYELID 38
996 FAILURE TO THRIVE 38
997 IMMOBILE 38
998 METASTASES TO CENTRAL NERVOUS SYSTEM 38
999 MOUTH ULCERATION 38